Canadian Antitrust Chief Vows To Tackle Pay-For-Delay Deals

Canada takes a tough approach to so-called "pay-for-delay" deals between brand-name and generic drugmakers and is working on ways to ramp up enforcement of those agreements, Canada's competition chief said Tuesday...

Already a subscriber? Click here to view full article